LY4405094
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 09, 2026
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=179 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders
August 27, 2026
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=179 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Alzheimer's Disease • CNS Disorders
August 27, 2026
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=68 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 3
Of
3
Go to page
1